Last reviewed · How we verify
NCT05471232
Mental Health Crises in Youth With IDDs
trial testing Genomic sequencing and molecular diagnostic results, if any. in Intellectual Disability in 150 participants. Currently enrolling.
1 July 2026
Quick facts
| Lead sponsor | Rady Pediatric Genomics & Systems Medicine Institute |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 29 March 2023 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 July 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Genomic sequencing and molecular diagnostic results, if any.
- EHR-Based Network Model
Conditions studied
- Intellectual Disability — all drugs for Intellectual Disability →
Sponsor
Rady Pediatric Genomics & Systems Medicine Institute
Who can join
Adults 7 to 17, any sex, with Intellectual Disability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is an unmatched, case-control study of 150 youth (Ages 7-17) with a parent reported Intellectual Developmental Disability (IDD) who present to Rady Children's Hospital Emergency Department with a Mental Health Crisis (MHC). Rady Children's Institute for Genomic Medicine (RCIGM) will collect biological samples (such as blood) of these participants to study their genomes, medical and psychiatric profiles to better understand specific characteristics that may predispose them to MHC's. The 150 youth will be compared to historical, publicly available cohorts of youth with IDD's
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05471232
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Genomic sequencing and molecular diagnostic results, if any.
Trials testing the same drug.
- NCT03211039 — Perinatal Precision Medicine · NA · unknown
Other recruiting trials for Intellectual Disability
Currently open trials in the same condition.
- NCT05473429 — Characterization of Nociception Phenotype in Individuals With Intellectual Disability · NA · recruiting
- NCT07497035 — Equine Therapy Programme on Stress, Autonomy and Balance in School-age Children With Intellectual Disabilities · NA · active not recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07278544 — Harnessing Communication Preferences · NA · recruiting
- NCT06829264 — Testing an Evidence-Based Supported Employment Model in Autistic Young Adults · NA · recruiting
Other Rady Pediatric Genomics & Systems Medicine Institute trials
Trials by the same sponsor.
- NCT06656572 — Immunogenomic Analyses of Pediatric Catatonia · NA · not yet recruiting
- NCT07504224 — ASD Wearables Feasibility Study · NA · completed
- NCT06276348 — Newborn Genomic Sequencing Pilot Study · NA · completed
- NCT03385876 — Rapid Whole Genome Sequencing Study · NA · enrolling by invitation
- NCT03211039 — Perinatal Precision Medicine · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05471232 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rady Pediatric Genomics & Systems Medicine Institute
- Last refreshed: 9 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05471232.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing